AssuredPartners Investment Advisors LLC purchased a new stake in Danaher Co. (NYSE:DHR – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 1,589 shares of the conglomerate’s stock, valued at approximately $365,000.
A number of other hedge funds have also bought and sold shares of the business. NEOS Investment Management LLC raised its position in shares of Danaher by 6.7% in the fourth quarter. NEOS Investment Management LLC now owns 43,990 shares of the conglomerate’s stock valued at $10,098,000 after buying an additional 2,778 shares in the last quarter. Sava Infond d.o.o. bought a new position in Danaher during the 4th quarter worth $744,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in Danaher by 7.5% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,023,696 shares of the conglomerate’s stock valued at $240,405,000 after acquiring an additional 71,540 shares in the last quarter. Korea Investment CORP lifted its position in shares of Danaher by 0.8% during the 4th quarter. Korea Investment CORP now owns 500,750 shares of the conglomerate’s stock valued at $114,947,000 after acquiring an additional 3,913 shares during the period. Finally, Mendel Money Management grew its holdings in shares of Danaher by 0.8% during the 4th quarter. Mendel Money Management now owns 22,447 shares of the conglomerate’s stock worth $5,153,000 after purchasing an additional 179 shares in the last quarter. 79.05% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
DHR has been the subject of several recent analyst reports. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a research report on Friday, March 14th. Barclays reduced their price target on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Robert W. Baird reduced their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $277.00 price target (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Five research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.24.
Danaher Price Performance
Shares of DHR opened at $205.69 on Friday. The business has a 50-day moving average of $214.57 and a 200-day moving average of $236.90. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a market capitalization of $147.01 billion, a price-to-earnings ratio of 38.96, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the company posted $2.09 EPS. As a group, equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is presently 24.24%.
Insider Activity
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by company insiders.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- How to Plot Fibonacci Price Inflection Levels
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- How to trade penny stocks: A step-by-step guide
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.